Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.

Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martínez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC, Meza-Montenegro MM, Peña EM, Peña R, Correa P, Martínez ME, Chey WD, Valdivieso M, Anderson GL, Goodman GE, Crowley JJ, Baker LH
JAMA. 2013 309 (6): 578-86

PMID: 23403682 · PMCID: PMC3697935 · DOI:10.1001/jama.2013.311

MeSH Terms (25)

2-Pyridinylmethylsulfinylbenzimidazoles Adult Amoxicillin Anti-Infective Agents Bismuth Breath Tests Clarithromycin Drug Administration Schedule Drug Therapy, Combination Enzyme Inhibitors Female Follow-Up Studies Helicobacter Infections Humans Lansoprazole Latin America Male Medication Adherence Metronidazole Middle Aged Primary Prevention Recurrence Risk Stomach Neoplasms Young Adult

Connections (3)

This publication is referenced by other Labnodes entities:

Links